A crucial sickle cell diagnosis technology developed by Prof. Debjani Paul and her team from the Department of Biosciences and Bioengineering was licensed exclusively to Lords Mark Ind. Pvt. Ltd. for field testing and commercialization. This socially-relevant technology includes a microscopy-based test that can distinguish between healthy, sickle traits, and sickle anaemia blood samples at the point of care.
We wish Prof. Paul and the Lord’s Mark team all the very best for their efforts toward the deployment of this impactful technology.